Oxidative stress–CBP axis modulates MOB1 acetylation and activates the Hippo signaling pathway
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Reactive oxygen species (ROS) are constantly produced in cells, an excess of which causes oxidative stress. ROS has been linked to regulation of the Hippo pathway; however, the underlying detailed mechanisms remain unclear. Here, we report that MOB1, a substrate of MST1/2 and co-activator of LATS1/2 in the canonical Hippo pathway, interacts with and is acetylated at lysine 11 by acetyltransferase CBP and deacetylated by HDAC6. MOB1-K11 acetylation stabilizes itself by reducing its binding capacity with E3 ligase Praja2 and subsequent ubiquitination. MOB1-K11 acetylation increases its phosphorylation and activates LATS1. Importantly, upstream oxidative stress signals promote MOB1 acetylation by suppressing CBP degradation, independent of MST1/2 kinase activity and HDAC6 deacetylation effect, thereby linking oxidative stress to activation of the Hippo pathway. Functionally, the acetylation-deficient mutant MOB1-K11R promotes lung cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo, compared to the wild-type MOB1. Clinically, acetylated MOB1 corresponds to better prediction of overall survival in patients with non-small cell lung cancer. Therefore, as demonstrated, an oxidative stress-CBP regulatory axis controls MOB1-K11 acetylation and activates LATS1, thereby activating the Hippo pathway and suppressing YAP/TAZ nuclear translocation and tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“LATS1 co-activator MOB1 is acetylated at K11 by CBP which interrupts MOB’s interaction with E3 ligase Praja2 and stabilizes the protein (Figure 5) [107].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [107]
The cited source says what the claim attributes to it.
In the citing paper
“This mechanism seemingly relies on its difference in deacetylases, LATS1 by SIRT3/4 [104] and MOB1 by HDAC6 [107], to fine tune Hippo/YAP signaling and modulate its function as both a tumor suppressor and tumor driver, again highlighting the issues of using pan KAT/KDAC inhibitors to probe these biological questions.”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 2×
“Once oxidation and antioxidation are out of balance, excessive accumulation of H 2 O 2 causes oxidative stress, subsequently promoting lipid oxidation and DNA damage (30,31).”
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Sanchez-Vega, F., Mina, M., Armenia, J., Chatila, W. K., Luna, A., La, K. C., Dimitriadoy, S., Liu, D. L., Kantheti, H. S., Saghafinia, S., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.035 · Cited by 3,201 · cited 1×
“An analysis, based on 9125 tumors in TCGA database, indicated that the Hippo pathway is one of the eight most frequently “altered” signaling pathways in human cancers, including lung cancer (19).”
Self-citationZhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“Furthermore, activated LATS1 / 2 promotes phosphorylation of YAP / TAZ, reduces YAP / TAZ nuclear translocation and inhibits the transcription of downstream target genes (16–18).”
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Hippo pathway in organ size control, tissue homeostasis, and cancer
Yu, F.-X., Zhao, B., & Guan, K.-L. (2015) · Cell · doi:10.1016/j.cell.2015.10.044 · Cited by 2,206
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667 · cited 1×
“MOB1 is an important component of the Hippo signaling pathway and is required for full activation of the Hippo core kinase LATS1 (3,12,57,58).”
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232 · cited 2×
“Furthermore, it was known that deacetylases are classified into two categories: histone deacetylase (HDAC) family and sirtuin (SIRT) family (46,47), the inhibitors of which are tricho-statin A (TSA) and nicotinamide, respectively.”
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version
Zhao, B., Li, L., Lei, Q., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1909210 · Cited by 1,144
Lei, Q.-Y., Zhang, H., Zhao, B., Zha, Z.-Y., Bai, F., Pei, X.-H., Zhao, S., Xiong, Y., & Guan, K.-L. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01874-07 · Cited by 924
Self-citationA Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span
Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villén, J., Becker, E. B. E., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.046 · Cited by 839
Tumor Suppressor LATS1 Is a Negative Regulator of Oncogene YAP
Hao, Y., Chun, A., Cheung, K., Rashidi, B., & Yang, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709037200 · Cited by 786
Barlev, N. A., Liu, L., Chehab, N. H., Mansfield, K., Harris, K. G., Halazonetis, T. D., & Berger, S. L. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00414-2 · Cited by 710 · cited 1×
“Acetylation is known to impact protein–protein interactions (48,49), subcellular localization (50), enzymatic activity (51–53), gene transcription (54), cellular metabolism (41) and protein stability (46), as seen in the regulation of the stability of EZH2 (55) and SRSF5 (56).”
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208445 · Cited by 584
Control of Cell Proliferation and Apoptosis by Mob as Tumor Suppressor, Mats
Lai, Z.-C., Wei, X., Shimizu, T., Ramos, E., Rohrbaugh, M., Nikolaidis, N., Ho, L.-L., & Li, Y. (2005) · Cell · doi:10.1016/j.cell.2004.12.036 · Cited by 568
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N., & Pan, D. (2013) · Cell · doi:10.1016/j.cell.2013.08.025 · Cited by 504
The Hippo Signaling Network and Its Biological Functions
Misra, J. R., & Irvine, K. D. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031621 · Cited by 497
The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program
Cai, J., Zhang, N., Zheng, Y., de Wilde, R. F., Maitra, A., & Pan, D. (2010) · Genes & Development · doi:10.1101/gad.1978810 · Cited by 492
Regulation of the p300 HAT domain via a novel activation loop
Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423
MOBKL1A/MOBKL1B Phosphorylation by MST1 and MST2 Inhibits Cell Proliferation
Praskova, M., Xia, F., & Avruch, J. (2008) · Current Biology · doi:10.1016/j.cub.2008.02.006 · Cited by 422
Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics
Ali, I., Conrad, R. J., Verdin, E., & Ott, M. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00181 · Cited by 366
Wang, Y.-P., Zhou, L.-S., Zhao, Y.-Z., Wang, S.-W., Chen, L.-L., Liu, L.-X., Ling, Z.-Q., Hu, F.-J., Sun, Y.-P., Zhang, J.-Y., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201387224 · Cited by 318
Acetylation of intrinsically disordered regions regulates phase separation
Saito, M., Hess, D., Eglinger, J., Fritsch, A. W., Kreysing, M., Weinert, B. T., Choudhary, C., & Matthias, P. (2019) · Nature Chemical Biology · doi:10.1038/s41589-018-0180-7 · Cited by 300
Wang, P., Geng, J., Gao, J., Zhao, H., Li, J., Shi, Y., Yang, B., Xiao, C., Linghu, Y., Sun, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08680-6 · Cited by 261
Self-citationMob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila
Wei, X., Shimizu, T., & Lai, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601630 · Cited by 205
Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode
Wang, D., Kon, N., Lasso, G., Jiang, L., Leng, W., Zhu, W.-G., Qin, J., Honig, B., & Gu, W. (2016) · Nature · doi:10.1038/nature19759 · Cited by 199
Cai, J., Fang, L., Huang, Y., Li, R., Yuan, J., Yang, Y., Zhu, X., Chen, B., Wu, J., & Li, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0297 · Cited by 194
The human tumour suppressor LATS1 is activated by human MOB1 at the membrane
Hergovich, A., Schmitz, D., & Hemmings, B. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.244 · Cited by 185
LATS1 tumor suppressor regulates G2/M transition and apoptosis
Hong, X., Qi, H., Li, Y., Pei, J., Barton, J., Blackstad, M., Xu, T., & Tao, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205174 · Cited by 179
DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation
Huang, H.-L., Fang, L., Lu, S.-P., Chou, C., Luh, T., & Lai, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206979 · Cited by 167
Wang, L., Wang, C., Tao, Z., Zhao, L., Zhu, Z., Wu, W., He, Y., Chen, H., Zheng, B., Huang, X., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1424-4 · Cited by 166
Zhou, L. S., Wang, Y., Yang, Y., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/0crd-8n84 · Cited by 164
Ni, L., Zheng, Y., Hara, M., Pan, D., & Luo, X. (2015) · Genes & Development · doi:10.1101/gad.264929.115 · Cited by 158
ARD1-mediated Hsp70 acetylation balances stress-induced protein refolding and degradation
Seo, J. H., Park, J., Lee, E. J., Vo, T. T. L., Choi, H., Kim, J. Y., Jang, J. K., Wee, H., Lee, H. S., Jang, S. H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12882 · Cited by 145
PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression
Wan, J., Zhan, J., Li, S., Ma, J., Xu, W., Liu, C., Xue, X., Xie, Y., Fang, W., Chin, Y. E., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv238 · Cited by 138
Self-citationSaccharomyces cerevisiae Mob1p Is Required for Cytokinesis and Mitotic Exit
Luca, F. C., Mody, M., Kurischko, C., Roof, D. M., Giddings, T. H., & Winey, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.20.6972-6983.2001 · Cited by 138
Wu, H., Xiao, Y., Zhang, S., Ji, S., Wei, L., Fan, F., Geng, J., Tian, J., Sun, X., Qin, F., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.020 · Cited by 127
Lignitto, L., Arcella, A., Sepe, M., Rinaldi, L., Delle Donne, R., Gallo, A., Stefan, E., Bachmann, V. A., Oliva, M. A., Tiziana Storlazzi, C., et al. (2013) · Nature Communications · doi:10.1038/ncomms2791 · Cited by 125
The c-Abl-MST1 Signaling Pathway Mediates Oxidative Stress-Induced Neuronal Cell Death
Xiao, L., Chen, D., Hu, P., Wu, J., Liu, W., Zhao, Y., Cao, M., Fang, Y., Bi, W., Zheng, Z., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0035-11.2011 · Cited by 123
Mechanisms of P/CAF auto-acetylation
Santos-Rosa, H. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg655 · Cited by 105
Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth
Chen, Y., Huang, Q., Liu, W., Zhu, Q., Cui, C.-P., Xu, L., Guo, X., Wang, P., Liu, J., Dong, G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04815-3 · Cited by 101
Self-citationMorinaka, A., Funato, Y., Uesugi, K., & Miki, H. (2011) · Oncogene · doi:10.1038/onc.2011.139 · Cited by 97
Hata, S., Hirayama, J., Kajiho, H., Nakagawa, K., Hata, Y., Katada, T., Furutani-Seiki, M., & Nishina, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334714 · Cited by 95
Li, L.-S., Fang, R., Liu, B., Shi, H., Wang, Y., Zhang, W., Zhang, X., & Ye, L. (2015) · Oncogene · doi:10.1038/onc.2015.476 · Cited by 94
Self-citationHou, M.-C., Wiley, D. J., Verde, F., & McCollum, D. (2003) · Journal of Cell Science · doi:10.1242/jcs.00206 · Cited by 88
Habtetsion, T. G., Ding, Z., Pi, W., Li, T., Lu, C., Chen, T., Xi, C., Spartz, H., Liu, K., Hao, Z., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.012 · Cited by 82
Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage
Cao, X., Li, C., Xiao, S., Tang, Y., Huang, J., Zhao, S., Li, X., Li, J., Zhang, R., & Yu, W. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608488114 · Cited by 77
Self-citationSarikhani, M., Mishra, S., Desingu, P. A., Kotyada, C., Wolfgeher, D. J., Gupta, M. P., Singh, M., & Sundaresan, N. R. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0069-8 · Cited by 73
Hirabayashi, S., Nakagawa, K., Sumita, K., Hidaka, S., Kawai, T., Ikeda, M., Kawata, A., Ohno, K., & Hata, Y. (2008) · Oncogene · doi:10.1038/onc.2008.66 · Cited by 66
Kindlin-2 Inhibits the Hippo Signaling Pathway by Promoting Degradation of MOB1
Song, J., Wang, T., Chi, X., Wei, X., Xu, S., Yu, M., He, H., Ma, J., Li, X., Du, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.035 · Cited by 66
Self-citationOtsubo, K., Goto, H., Nishio, M., Kawamura, K., Yanagi, S., Nishie, W., Sasaki, T., Maehama, T., Nishina, H., Mimori, K., et al. (2017) · Oncogene · doi:10.1038/onc.2017.58 · Cited by 57
Chen, T., Zhao, L., Chen, S., Zheng, B., Chen, H., Zeng, T., Sun, H., Zhong, S.-J., Wu, W., Lin, X., et al. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111131 · Cited by 57
Regulation of the histone acetyltransferase activity of hMOF via autoacetylation of Lys274
Sun, B., Guo, S., Tang, Q., Li, C., Zeng, R., Xiong, Z., Zhong, C., & Ding, J. (2011) · Cell Research · doi:10.1038/cr.2011.105 · Cited by 54
Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo
Xu, C., Liu, W. W., Liu, C. J., Wen, C., Lü, H., & Wan, F. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.40 · Cited by 52
Human MOB1 Expression in Non–Small-Cell Lung Cancer
Sasaki, H., Kawano, O., Endo, K., Suzuki, E., Yukiue, H., Kobayashi, Y., Yano, M., & Fujii, Y. (2007) · Clinical Lung Cancer · doi:10.3816/clc.2007.n.006 · Cited by 40
Structural basis for autoinhibition and its relief of MOB1 in the Hippo pathway
Kim, S., Tachioka, Y., Mori, T., & Hakoshima, T. (2016) · Scientific Reports · doi:10.1038/srep28488 · Cited by 36
Rajesh, K., Krishnamoorthy, J., Gupta, J., Kazimierczak, U., Papadakis, A. I., Deng, Z., Wang, S., Kuninaka, S., & Koromilas, A. E. (2016) · Oncotarget · doi:10.18632/oncotarget.10480 · Cited by 34
Combinatorial regulation of a signal-dependent activator by phosphorylation and acetylation
Paz, J. C., Park, S., Phillips, N., Matsumura, S., Tsai, W., Kasper, L. H., Brindle, P. K., Zhang, G., Zhou, M., Wright, P. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420389111 · Cited by 28
TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1
Roh, K.-H., & Choi, E. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.010 · Cited by 28
PTEN–GSK3β–MOB1 axis controls neurite outgrowth in vitro and in vivo
Song, Z., Han, X., Zou, H., Zhang, B., Ding, Y., Xu, X., Zeng, J., Liu, J., & Gong, A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2890-0 · Cited by 25
Yang, S., Xu, W., Liu, C., Jin, J., Li, X., Jiang, Y., Zhang, L., Meng, X., Zhan, J., & Zhang, H. (2022) · Science China Life Sciences · doi:10.1007/s11427-020-1914-3 · Cited by 24 · cited 1×
“A series of studies have also confirmed that MST1 (27), LATS1 (28) and YAP (29) can be acetylated, and all of them have a significant impact on the molecular functions and activation of the Hippo signaling pathway.”
Self-citationDeacetylation of CHK2 by SIRT1 protects cells from oxidative stress-dependent DNA damage response
Kwon, J., Lee, S., Kim, Y.-N., & Lee, I. H. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0232-4 · Cited by 22
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells
Cucci, M. A., Compagnone, A., Daga, M., Grattarola, M., Ullio, C., Roetto, A., Palmieri, A., Rosa, A. C., Argenziano, M., Cavalli, R., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.06.009 · Cited by 21
Ando, N., Tanaka, K., Otsubo, K., Toyokawa, G., Ikematsu, Y., Ide, M., Yoneshima, Y., Iwama, E., Inoue, H., Ijichi, K., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13608 · Cited by 5
MOB1 Inhibits Malignant Progression of Colorectal Cancer by Targeting PAK2
Liu, J., Shi, Z., Ma, Y., Fu, L., & Yi, M. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s253470 · Cited by 4
Li, C., & Yu, W. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1293597 · Cited by 3
Research works printed but not linked: 1
- Cao, 2017, Acetylation promotes TyrRS nuclear translocation to prevent oxidative damage, Proc. Natl. Acad. Sci. U.S.A., 114, 687, 10.1073/pnas.1608488114 · DOI
Cited by
Wu, H., Liu, Q., Yang, N., & Xu, S. (2023) · Science of The Total Environment · doi:10.1016/j.scitotenv.2023.161962 · Cited by 223
Zeng, L., Zhou, C., Xu, W., Huang, Y., Wang, W., Ma, Z., Huang, J., Li, J., Hu, L., Xue, Y., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.114941 · Cited by 117
Self-citationHorváth, E., Sólyom, Á., Székely, J., Nagy, E. E., & Popoviciu, H. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216468 · Cited by 127
Oxidative stress is the pivot for PM2.5-induced lung injury
Hou, T., Zhu, L., Wang, Y., & Peng, L. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114362 · Cited by 109
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Tao, L., Zhou, Y., Luo, Y., Qiu, J., Xiao, Y., Zou, J., Zhang, Y., Liu, X., Yang, X., Gou, K., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.59 · Cited by 111
Metadata
- Authors
- Jin, J., Zhang, L., Li, X., Xu, W., Yang, S., Song, J., Zhang, W., Zhan, J., Luo, J., & Zhang, H.
- Affiliations
- Peking University (CN)
- Tsinghua University (CN)
- Corresponding author
- Zhang, Hongquan
- ORCID
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2022-03-29
- Volume
- 50
- Issue
- 7
- Pages
- 3817-3834
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC9023286
- OpenAlex
- W4221109755
- Cited by
- 99
- References
- 68
- Citations by year
- 2026: 30 · 2025: 32 · 2024: 18 · 2023: 18 · 2022: 1
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Ministry of Science and Technology of China (2021YFC2501000)
- National Natural Science Foundation of China (81730071, 81972616, 81230051, 81972609, 81773199)
- Beijing Natural Science Foundation (7171005, 7202084)
- Shanghai Science and Technology Commission (20JC1410100)
- Peking University grant (PKU2021LCXQ023)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- MOB1, CBP, oxidative stress, reactive oxygen species, Hippo signaling pathway, lysine acetylation, HDAC6, LATS1, MST1/2, ubiquitination, non-small cell lung cancer, tumor progression, prognostic factors
- MeSH terms
- Hippo Signaling Pathway, Acetylation, Carcinoma, Non-Small-Cell Lung, Humans, Lung Neoplasms, Protein Serine-Threonine Kinases, Reactive Oxygen Species, Oxidative Stress, Chemokine CXCL10
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.